Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07661550 · ClinicalTrials.gov registry record · NA

Prevention of Postpartum Smoking Relapse and Related Health Consequences by Breastfeeding Promotion

A NA study, sponsored by State University of New York at Buffalo.

Recruiting
Registry status
NA
Development phase
280
Enrollment target

NCT07661550 is a NA study that is actively recruiting participants, run by State University of New York at Buffalo. The registered enrollment target is 280 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07661550, a NA study, is actively recruiting participants, sponsored by State University of New York at Buffalo.

RECRUITING
Registry status
NA
Development phase
280 participants
Enrollment target

Study Summary

The objective of this randomized controlled trial is to examine the efficacy of a new intervention to prevent postpartum smoking relapse and related health consequences through breastfeeding promotion. After the pre-test, ex-smokers who are still abstinent from smoking will be randomized into either the breastfeeding intervention or the attention placebo control group. The outcomes are postpartum smoking relapse, breastfeeding practices, and maternal and child health.

Interventions

  • BEHAVIORAL Breastfeeding promotion
  • BEHAVIORAL Attention placebo control

Trial Details

FieldValue
Enrollment Target 280 participants
Start Date 2026-01-01
Est. Completion 2031-07-31
Phase NA

What the Registry Record Tells You About NCT07661550

The ClinicalTrials.gov registry entry for NCT07661550 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 280 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Breastfeeding promotion is the first listed.

NCT07661550 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07661550 about?

NCT07661550 is a clinical study titled "Prevention of Postpartum Smoking Relapse and Related Health Consequences by Breastfeeding Promotion". The objective of this randomized controlled trial is to examine the efficacy of a new intervention to prevent postpartum smoking relapse and related health consequences through breastfeeding promotion. After the pre-test, ex-smokers who are still abstinent from smoking will be randomized into either...

What is the current status of trial NCT07661550?

This trial is currently recruiting. It is a NA study. The enrollment target is 280 participants. The study started on 2026-01-01. Estimated completion is 2031-07-31.

What interventions are being tested in trial NCT07661550?

The interventions under investigation include: Breastfeeding promotion (BEHAVIORAL), Attention placebo control (BEHAVIORAL).

Who is sponsoring clinical trial NCT07661550?

This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.